- In June 2026, CooperCompanies released its 2025 Corporate Sustainability Report, expanding ESG disclosures with first-time Scope 3 emissions reporting and alignment with SASB and TCFD, while also outlining innovation progress in vision care and women’s health alongside ongoing operational challenges from Asia-Pacific softness and recall-related litigation costs.
- This combination of deeper climate transparency and product development updates gives investors clearer visibility into how CooperCompanies is managing environmental obligations while balancing growth initiatives and current business headwinds.
- We’ll now examine how the new Scope 3 emissions disclosure and broader sustainability progress could influence CooperCompanies’ existing investment narrative.
The latest GPUs need a type of rare earth metal called Neodymium and there are only 31 companies in the world exploring or producing it. Find the list for free.
Cooper Companies Investment Narrative Recap
To own CooperCompanies, you need to believe in its ability to grow premium contact lenses and women’s health while managing pricing pressure, Asia Pacific softness, and recall-related litigation. The new sustainability report, including first-time Scope 3 emissions disclosure, does not materially change the near term focus on stabilizing profitability and execution in key markets, but it does add another lens for assessing how the business is being run.
The Scope 3 emissions disclosure and alignment with SASB and TCFD are especially relevant now because they sit alongside ongoing operational issues in Asia Pacific and recall-driven legal costs. This combination gives you more context for weighing short term earnings headwinds against longer term efforts in innovation, compliance, and reputation that could matter for how reliably CooperCompanies can fund its growth plans.
Yet behind the progress on sustainability reporting, there is a risk investors should be aware of if Asia Pacific pricing and recall litigation were to...
Read the full narrative on Cooper Companies (it's free!)
Cooper Companies' narrative projects $4.9 billion revenue and $817.1 million earnings by 2029. This requires 5.1% yearly revenue growth and about a $581.3 million earnings increase from $235.8 million today.
Uncover how Cooper Companies' forecasts yield a $80.57 fair value, a 12% upside to its current price.
Exploring Other Perspectives
By contrast, the most cautious analysts, who were assuming only about 4.5% annual revenue growth and earnings of roughly US$808.6 million by 2029, highlight how views can differ widely and why fresh information like CooperCompanies’ expanded Scope 3 reporting might lead you to revisit both the downside concerns and the potential resilience in premium lenses or myopia control products over time.
Explore 5 other fair value estimates on Cooper Companies - why the stock might be worth 40% less than the current price!
Reach Your Own Conclusion
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
- A great starting point for your Cooper Companies research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.
- Our free Cooper Companies research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Cooper Companies' overall financial health at a glance.
Ready For A Different Approach?
Our daily scans reveal stocks with breakout potential. Don't miss this chance:
- Invest in the nuclear renaissance through our list of 89 elite nuclear energy infrastructure plays powering the global AI revolution.
- AI is about to change healthcare. These 39 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
- Find 41 companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com